Filing Details
- Accession Number:
- 0001127602-19-026120
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-06 11:42:42
- Reporting Period:
- 2019-08-01
- Accepted Time:
- 2019-08-06 11:42:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 816956 | Conmed Corp | CNMD | Electromedical & Electrotherapeutic Apparatus (3845) | 160977505 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1404850 | Dirk Kuyper | C/O Conmed Corporation 525 French Road Utica NY 13502 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-08-02 | 5,396 | $41.06 | 10,396 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-08-02 | 5,396 | $91.10 | 5,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-08-02 | 3,669 | $51.90 | 8,669 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-08-02 | 3,669 | $91.04 | 5,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-08-02 | 2,549 | $69.03 | 7,549 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-08-02 | 2,549 | $91.17 | 5,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options To Purchase Common Stock | Disposition | 2019-08-01 | 2,165 | $0.00 | 2,165 | $79.94 |
| Common Stock | Rsus (restricted Stock Units) | Disposition | 2019-08-01 | 1,407 | $0.00 | 1,407 | $0.00 |
| Common Stock | Options To Purchase Common Stock | Disposition | 2019-08-02 | 5,396 | $0.00 | 5,396 | $41.06 |
| Common Stock | Options To Purchase Common Stock | Disposition | 2019-08-02 | 3,669 | $0.00 | 3,669 | $51.90 |
| Common Stock | Options To Purchase Common Stock | Disposition | 2019-08-02 | 2,549 | $0.00 | 2,549 | $69.03 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-06-01 | 2029-06-03 | No | 4 | D | Direct |
| 0 | 2020-06-01 | 2029-06-03 | No | 4 | D | Direct |
| 0 | 2017-06-01 | 2026-06-01 | No | 4 | M | Direct |
| 0 | 2018-06-01 | 2027-06-01 | No | 4 | M | Direct |
| 0 | 2019-06-01 | 2028-06-01 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.00 to $91.68. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.00 to $91.19. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.00 to $91.33. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The stock options expired without vesting as a consequence of Mr. Kuyper's resignation from the Board prior to the completion of the 2019 term of service.
- The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.
- The RSUs expired without vesting as a consequence of Mr. Kuyper's resignation from the Board prior to the completion of the 2019 term of service.
- Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.
Billionaire Hedge Funds
